Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: The long-term relative risk of antihypertensive treatments with regard to mortality and morbidity is not well understood. OBJECTIVE: To determine the long-term posttrial risk of primary and secondary outcomes among trial participants who were randomized to either a thiazide-type diuretic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamal, Jose-Miguel, Martinez, Journey, Osani, Mikala C., Du, Xianglin L., Simpson, Lara M., Davis, Barry R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696481/
https://www.ncbi.nlm.nih.gov/pubmed/38048133
http://dx.doi.org/10.1001/jamanetworkopen.2023.44998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696481/
https://www.ncbi.nlm.nih.gov/pubmed/38048133
http://dx.doi.org/10.1001/jamanetworkopen.2023.44998

Ejemplares similares